Business Context and Reporting Period
Company: Oaktree Specialty Lending Corporation (OCSL)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2020
Business Overview: OCSL is a closed-end, externally managed Business Development Company (BDC) regulated under the Investment Company Act of 1940. It provides customized credit solutions, including first and second lien loans, mezzanine loans, and equity co-investments, primarily to middle-market companies. The company is externally managed by Oaktree Fund Advisors, LLC.
Key Financial Metrics
| Metric (in thousands, except per share) | Three Months Ended June 30, 2020 | Nine Months Ended June 30, 2020 | Three Months Ended June 30, 2019 | Nine Months Ended June 30, 2019 |
|---|---|---|---|---|
| Total Investment Income | $34,403 | $99,534 | $36,669 | $113,189 |
| Net Investment Income | $16,770 | $47,447 | $16,608 | $51,634 |
| Net Realized Gains (Losses) | $2,821 | $(20,371) | $(19,844) | $23,331 |
| Net Unrealized Appreciation (Depreciation) | $100,572 | $(60,082) | $23,395 | $37,892 |
| Net Increase (Decrease) in Net Assets | $120,231 | $(31,393) | $19,986 | $112,189 |
| Earnings (Loss) Per Share (Basic & Diluted) | $0.85 | $(0.22) | $0.14 | $0.80 |
| Net Asset Value (NAV) Per Share | $6.09 | $6.09 | $6.60 | $6.60 |
| Total Assets | $1,647,567 | $1,647,567 | $1,481,038 | $1,481,038 |
| Total Liabilities | $788,504 | $788,504 | $550,408 | $550,408 |
| Net Assets | $859,063 | $859,063 | $930,630 | $930,630 |
| Cash and Cash Equivalents | $50,728 | $50,728 | $15,406 | $15,406 |
Debt and Liquidity
- Credit Facility: $466.8 million outstanding as of June 30, 2020 (up from $314.8 million at Sept 30, 2019). The facility size is $700 million with an accordion feature up to $800 million or net worth.
- Unsecured Notes: $294.2 million outstanding (net of unamortized costs). This includes $300.0 million of 3.500% notes due 2025 issued in February 2020. The company redeemed all 2024 Notes ($75.0 million) and 2028 Notes ($86.3 million) in March 2020.
- Asset Coverage Ratio: 211.27% as of June 30, 2020 (above the 150% minimum requirement).
- Debt-to-Equity Ratio: 0.89x as of June 30, 2020.
Material Changes vs. Prior Period
- Investment Income Decline: Total investment income decreased by 6.2% for the quarter and 12.1% for the nine-month period compared to the prior year. This was primarily driven by lower LIBOR rates affecting floating-rate investments and reduced dividend income from specific portfolio companies (e.g., First Star Speir Aviation Limited).
- Expense Reduction: Net expenses decreased by 12.1% for the quarter and 15.4% for the nine-month period. This was largely due to lower interest expense (driven by LIBOR decreases) and a reduction in incentive fees.
- Realized Losses: The nine-month period ended June 30, 2020, recorded net realized losses of $20.4 million, contrasting with net realized gains of $23.3 million in the prior year. Significant losses were recognized on exits/restructurings of Cenegenics, LLC ($29.2 million loss) and Dominion Diagnostics, LLC ($15.6 million loss), partially offset by gains on YETI Holdings, Inc. ($17.6 million gain).
- Unrealized Volatility: The quarter ended June 30, 2020, saw a significant net unrealized appreciation of $100.6 million, driven by tighter credit spreads and price increases on liquid debt investments. However, the nine-month period showed a net unrealized depreciation of $60.1 million.
- Portfolio Composition: Total investments at fair value increased to $1.56 billion (181.7% of net assets) from $1.44 billion (154.5% of net assets) at the prior fiscal year-end. Senior secured debt remains the dominant asset class (80.9% of portfolio).
Guidance, Outlook, and Risks
- COVID-19 Impact: Management highlights significant uncertainty due to the pandemic. While initial market disruptions have eased, economic uncertainty persists. The company has proactively engaged with portfolio companies to assess liquidity and solvency. Some portfolio companies have halted operations or faced supply chain disruptions.
- Interest Rate Risk: 86.2% of the debt portfolio is floating-rate. A prolonged reduction in LIBOR decreases investment income. The company notes that if LIBOR ceases to exist (phased out by end of 2021), it may need to renegotiate credit agreements.
- Distressed Investments: The company has opportunistically acquired securities of distressed companies due to the pandemic. These investments carry risks of lack of income, extraordinary expenses, and uncertainty regarding debt satisfaction.
- Distributions: On July 31, 2020, the Board declared a quarterly distribution of $0.105 per share, payable September 30, 2020. The company intends to distribute at least 90% of annual taxable income to maintain RIC status.
- Liquidity: Management believes liquidity resources (cash, undrawn credit facility capacity, and ability to rotate assets) are sufficient to take advantage of market opportunities despite the economic climate.
Key Facts for Investor Verification
- NAV Decline: Verify the impact of the $71.6 million decrease in net assets over the nine-month period on the long-term value proposition, despite the strong quarterly unrealized appreciation.
- Realized Loss Drivers: Review the specific details of the $29.2 million loss on Cenegenics and $15.6 million loss on Dominion Diagnostics to understand the credit quality of the portfolio.
- Debt Refinancing: Confirm the terms and sustainability of the new $300 million 2025 Notes issued in February 2020, which replaced higher-cost 2024 and 2028 notes.
- LIBOR Sensitivity: Assess the company's hedging strategies or fallback provisions for the transition away from LIBOR, given that 86.2% of the debt portfolio is floating-rate.
- Non-Accrual Status: Monitor the three investments on non-accrual status (representing 1.3% of debt portfolio at cost) and their potential impact on future income.